Fraga Francisco has reported several stock transactions involving McKesson Corp, a prominent player in the wholesale drugs industry. This update is significant as it highlights ongoing changes in ownership and management strategies within the company.

Background

Fraga Francisco is an executive at McKesson Corp, which is involved in the wholesale distribution of drugs and health-related products. The company is listed under the Central Index Key (CIK) 0000927653, and its operations are primarily focused on the wholesale-drugs sector.

What the Filing Says

The recent filing, accession number 0000927653-26-000286, details multiple transactions by Francisco. On November 3, 2026, he acquired 398 shares of common stock through restricted stock units (RSUs) that vested. Additionally, he sold 600 shares on November 4, 2026, at a price of $1,050.00 per share, as part of a previously adopted plan.

Impact

These transactions may affect the overall ownership structure of McKesson Corp. Francisco's actions reflect a proactive approach in managing his equity in the company, which could influence investor perceptions and corporate governance.

What's Next

The filing does not say what happens next.

Details of Transactions

In addition to the acquisition of 398 shares through restricted stock units (RSUs) that vested on November 3, 2026, Francisco also disposed of 157 shares on the same day, which were withheld to cover taxes related to the RSUs. Following these transactions, he reported owning a total of 5,664.496 shares of McKesson Corp.

On November 4, 2026, he sold an additional 600 shares at a price of $1,050.00 per share, as part of a previously adopted trading plan established on March 10, 2026, which complies with Rule 10b5-1(c). After this sale, his remaining share ownership decreased to 5,064.496 shares.

Officer Role

Fraga Francisco holds the title of Executive Vice President (EVP), Chief Information Officer (CIO), and Chief Technology Officer (CTO) at McKesson Corp. His role is pivotal in overseeing the company's technological advancements and information systems, which are crucial for the operational efficiency of the wholesale drug distribution business.

Company Overview

McKesson Corp operates within the wholesale-drugs sector, classified under the Standard Industrial Classification (SIC) code 5122. The company is incorporated in Delaware and has its business address in Irving, Texas. McKesson has a fiscal year that ends on March 31.

Filing Context

The filing does not provide further insights into future transactions or plans regarding Francisco's stock holdings or the overall strategic direction of McKesson Corp.